Telecom Sector Regulation in India: An Institutional Perspective, Maruthi P. Tangirala

Автор: Murali Krishna Medudula; Mahim Sagar; Ravi Parkash
Название: Telecom Management in Emerging Economies
ISBN: 8132227476 ISBN-13(EAN): 9788132227472
Издательство: Springer
Рейтинг:
Цена: 107130.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.

Автор: Dutta Dilip
Название: Inclusive Growth And Development In The 21St Century: A Structural And Institutional Analysis Of China And India
ISBN: 9814556882 ISBN-13(EAN): 9789814556880
Издательство: World Scientific Publishing
Рейтинг:
Цена: 95040.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Using case studies of both China and India, this book reinforces the fact that the processes of economic growth and development are dynamic and organic in the sense that structural and institutional elements are not only interrelated, but also constantly changing in their patterns of interactions -- more so during the transitional period of both countries. Inclusiveness or its lack in some specific socio-economic sector/context, geographical region/state or economy as a whole is critically analysed, using recent data on both the countries from different sources.

Автор: Thanu Padmanabhan
Название: Astronomy in India: A Historical Perspective
ISBN: 8132228448 ISBN-13(EAN): 9788132228448
Издательство: Springer
Рейтинг:
Цена: 95770.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: India has a strong and ancient tradition of astronomy, which seamlessly merges with the current activities in Astronomy and Astrophysics in the country.

Автор: ICRIER Health Policy Initiative
Название: Challenges and Prospects for Clinical Trials in India: A Regulatory Perspective
ISBN: 9332704260 ISBN-13(EAN): 9789332704268
Издательство: Mare Nostrum (Eurospan)
Рейтинг:
Цена: 68550.00 T
Наличие на складе: Невозможна поставка.
Описание: With the evolution of India`s disease burden as well as its pharmaceutical industry, the need for clinical trials has increased. This report analyses the prospects and challenges of clinical trials in India, focusing on new chemical entities and new drugs, and proposes actionable policy recommendations for the Indian drug regulatory landscape.